rs74315287
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM1PM2PP3_ModeratePP5_Very_Strong
The NM_057176.3(BSND):c.28G>A(p.Gly10Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00000372 in 1,614,114 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. G10G) has been classified as Likely benign.
Frequency
Consequence
NM_057176.3 missense
Scores
Clinical Significance
Conservation
Publications
- Bartter disease type 4AInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, G2P, PanelApp Australia
- Bartter syndrome type 4Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152158Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251420 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1461838Hom.: 0 Cov.: 32 AF XY: 0.00000275 AC XY: 2AN XY: 727226 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152276Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74450 show subpopulations
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Published functional studies demonstrate the variant eliminates function of CIC-K channels despite not altering channel formation (PMID: 18776122); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 12111250, 24189473, 12761627, 30405442, 30977917, 30174009, 19096086, 19309509, 12574213, 33348466, 11734858, 11687798, 18776122) -
This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 10 of the BSND protein (p.Gly10Ser). This variant is present in population databases (rs74315287, gnomAD 0.003%). This missense change has been observed in individual(s) with Bartter syndrome with sensorineural deafness (PMID: 11687798, 26857709). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 4385). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BSND protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects BSND function (PMID: 11734858, 18776122). For these reasons, this variant has been classified as Pathogenic. -
Bartter disease type 4A Pathogenic:1
- -
Bartter syndrome Pathogenic:1
Variant summary: BSND c.28G>A (p.Gly10Ser) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251420 control chromosomes in gnomAD. c.28G>A has been reported in the literature in multiple individuals and families affected with Bartter Syndrome, Type 4a (example: Landau_2016, Birkenhager_2001, Brennan_1998, Mori_2020). Most of such individuals are Arabian in Israel, suggesting c.28G>A is a founder mutation of Bartter Syndrome Type 4a in the Arabians. At least one publication reports experimental evidence evaluating an impact on protein function and showed that this variant abolishes plasmalemmal ClC-K/barttin currents in the human kidney (Janssen_2009). These data indicate that the variant is very likely associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 11687798, 18776122, 26857709, 33348466, 9463315). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at